科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/16 | 4,305 | 4,320 | 4,280 | 4,305 | +65 | +1.5% | 66,000 |
| 2022/02/15 | 4,250 | 4,275 | 4,220 | 4,240 | +5 | +0.1% | 51,100 |
| 2022/02/14 | 4,180 | 4,240 | 4,140 | 4,235 | +40 | +1% | 72,800 |
| 2022/02/10 | 4,160 | 4,205 | 4,160 | 4,195 | +35 | +0.8% | 98,200 |
| 2022/02/09 | 4,160 | 4,170 | 4,140 | 4,160 | +20 | +0.5% | 59,300 |
| 2022/02/08 | 4,125 | 4,170 | 4,125 | 4,140 | +35 | +0.9% | 59,000 |
| 2022/02/07 | 4,070 | 4,130 | 4,070 | 4,105 | +10 | +0.2% | 64,300 |
| 2022/02/04 | 4,105 | 4,115 | 4,050 | 4,095 | -95 | -2.3% | 91,900 |
| 2022/02/03 | 4,200 | 4,225 | 4,180 | 4,190 | -10 | -0.2% | 58,300 |
| 2022/02/02 | 4,150 | 4,210 | 4,140 | 4,200 | +55 | +1.3% | 52,100 |
| 2022/02/01 | 4,100 | 4,175 | 4,095 | 4,145 | +45 | +1.1% | 57,000 |
| 2022/01/31 | 4,180 | 4,180 | 4,085 | 4,100 | -105 | -2.5% | 92,100 |
| 2022/01/28 | 4,210 | 4,230 | 4,185 | 4,205 | +60 | +1.4% | 61,300 |
| 2022/01/27 | 4,195 | 4,215 | 4,125 | 4,145 | -25 | -0.6% | 88,100 |
| 2022/01/26 | 4,240 | 4,240 | 4,160 | 4,170 | -55 | -1.3% | 53,800 |
| 2022/01/25 | 4,215 | 4,260 | 4,195 | 4,225 | -50 | -1.2% | 66,300 |
| 2022/01/24 | 4,180 | 4,280 | 4,180 | 4,275 | +40 | +0.9% | 75,800 |
| 2022/01/21 | 4,215 | 4,235 | 4,175 | 4,235 | +25 | +0.6% | 71,300 |
| 2022/01/20 | 4,230 | 4,275 | 4,195 | 4,210 | -15 | -0.4% | 92,700 |
| 2022/01/19 | 4,220 | 4,260 | 4,210 | 4,225 | -35 | -0.8% | 87,100 |
| 2022/01/18 | 4,330 | 4,335 | 4,245 | 4,260 | -40 | -0.9% | 58,300 |
| 2022/01/17 | 4,295 | 4,345 | 4,270 | 4,300 | -20 | -0.5% | 50,000 |
| 2022/01/14 | 4,255 | 4,320 | 4,245 | 4,320 | +65 | +1.5% | 88,100 |
| 2022/01/13 | 4,255 | 4,270 | 4,220 | 4,255 | +10 | +0.2% | 62,200 |
| 2022/01/12 | 4,205 | 4,260 | 4,205 | 4,245 | +40 | +1% | 58,200 |
| 2022/01/11 | 4,195 | 4,230 | 4,180 | 4,205 | +50 | +1.2% | 55,100 |
| 2022/01/07 | 4,180 | 4,210 | 4,140 | 4,155 | -35 | -0.8% | 62,300 |
| 2022/01/06 | 4,190 | 4,240 | 4,190 | 4,190 | -10 | -0.2% | 45,100 |
| 2022/01/05 | 4,230 | 4,230 | 4,195 | 4,200 | -45 | -1.1% | 55,300 |
| 2022/01/04 | 4,220 | 4,255 | 4,210 | 4,245 | +35 | +0.8% | 55,600 |
| 2021/12/30 | 4,250 | 4,250 | 4,210 | 4,210 | -55 | -1.3% | 47,100 |
| 2021/12/29 | 4,240 | 4,295 | 4,240 | 4,265 | +45 | +1.1% | 55,200 |
| 2021/12/28 | 4,180 | 4,230 | 4,170 | 4,220 | +35 | +0.8% | 41,600 |
| 2021/12/27 | 4,200 | 4,200 | 4,170 | 4,185 | -30 | -0.7% | 26,800 |
| 2021/12/24 | 4,230 | 4,240 | 4,200 | 4,215 | ±0 | ±0% | 33,600 |
| 2021/12/23 | 4,265 | 4,275 | 4,205 | 4,215 | -15 | -0.4% | 38,600 |
| 2021/12/22 | 4,240 | 4,265 | 4,215 | 4,230 | -10 | -0.2% | 50,800 |
| 2021/12/21 | 4,230 | 4,280 | 4,230 | 4,240 | +15 | +0.4% | 60,300 |
| 2021/12/20 | 4,195 | 4,230 | 4,175 | 4,225 | +5 | +0.1% | 74,900 |
| 2021/12/17 | 4,215 | 4,245 | 4,195 | 4,220 | -10 | -0.2% | 107,700 |
| 2021/12/16 | 4,225 | 4,235 | 4,195 | 4,230 | +60 | +1.4% | 53,000 |
| 2021/12/15 | 4,145 | 4,200 | 4,145 | 4,170 | ±0 | ±0% | 42,800 |
| 2021/12/14 | 4,130 | 4,190 | 4,130 | 4,170 | +55 | +1.3% | 66,100 |
| 2021/12/13 | 4,175 | 4,175 | 4,110 | 4,115 | -20 | -0.5% | 51,100 |
| 2021/12/10 | 4,140 | 4,150 | 4,115 | 4,135 | -50 | -1.2% | 75,200 |
| 2021/12/09 | 4,260 | 4,260 | 4,165 | 4,185 | -40 | -0.9% | 54,300 |
| 2021/12/08 | 4,235 | 4,250 | 4,205 | 4,225 | -15 | -0.4% | 86,000 |
| 2021/12/07 | 4,195 | 4,240 | 4,150 | 4,240 | +85 | +2% | 93,300 |
| 2021/12/06 | 4,210 | 4,240 | 4,150 | 4,155 | -15 | -0.4% | 58,200 |
| 2021/12/03 | 4,085 | 4,175 | 4,085 | 4,170 | +85 | +2.1% | 76,200 |
851～
900
件表示中 / 3757件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 401,900円 | -6.4% | -71.8% | 4.73% | 44.89倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 450,000円 | +3.6% | - | 2.67% | 15.17倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 244,500円 | - | - | 0.00% | - | 113.25倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 341,500円 | +7.9% | -3.3% | 2.34% | 9.50倍 | 0.98倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
